Medical Technology News | MedTech Dive
WEBThe European Commission lacked oversight authority to examine the proposed sale of a cancer-detection company to biotech company Illumina, the court found. MedTech Dive provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA …
Medical Device News - MedTech Dive
WEB2 days ago · Merit Medical inks $210M takeover of Cook’s lead management business. Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales. By Nick Paul Taylor • …
Grail to shed 350 workers in restructuring - MedTech Dive
WEBAug 14, 2024 · Grail said it will lay off about 350 employees in a restructuring that comes less than two months after the maker of a cancer blood test separated from Illumina. The job cuts represent 25% of its workforce as of June 30. The standalone company will reprioritize its resources to focus on the Galleri multi …
Dexcom’s G7 glucose monitor wins awaited FDA clearance
WEBDec 8, 2022 · The device, which Dexcom plans to start selling in the U.S. early next year, is cleared for people with Type 1 and Type 2 diabetes, as well as gestational diabetes. Published Dec. 8, 2022. Elise Reuter Reporter. Dexcom won FDA approval to begin selling its G7 continuous glucose monitor in the U.S. later …
Medtronic completes Intersect acquisition following FTC order
WEBUPDATE: May 16, 2022: Medtronic has completed its acquisition of Intersect ENT, adding to the company’s ear, nose and throat portfolio. The Friday announcement follows a requirement from the Federal Trade Commission for Medtronic to divest Fiagon, a subsidiary of Intersect, for the deal to go through.. Medtronic will acquire Intersect’s Propel and Sinuva sinus implant product lines and ...
MedTech Mergers & Acquisitions | MedTech Dive
WEB4 days ago · Merit Medical inks $210M takeover of Cook’s lead management business. Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales. By Nick Paul Taylor • …
Boston Scientific’s spinal cord stimulators approved for non …
WEBFeb 7, 2024 · Boston Scientific has won approval for its Wavewriter spinal cord stimulator (SCS) systems in non-surgical back pain (NSBP). The U.S. Food and Drug Administration approval expands the label of the Wavewriter systems to cover the treatment of chronic low back and leg pain in people without prior back surgery. The …
CMS eases breakthrough device path to reimbursement in final rule
WEBAug 5, 2019 · Dive Brief: Manufacturers of breakthrough devices may have an easier path to CMS reimbursement under an alternative new technology add-on payment model outlined in the Inpatient Prospective Payment System rule for 2020, finalized Friday.; The policy requires an FDA-designated and authorized breakthrough device to meet certain cost criteria to receive the add-on payment rather than demonstrate ...
Abbott recalls Freestyle Libre 3 sensors due to incorrect glucose ...
WEBJul 26, 2024 · Abbott has recalled a small number of Freestyle Libre 3 sensors distributed in the U.S. in the first half of May, the company said Wednesday. Internal testing found a subset of three lots of the continuous glucose monitor (CGM) sensors may provide incorrect high glucose readings, the company said. The false readings could lead to incorrect ...
A better way to manage medical device inventory - MedTech Dive
WEBMar 27, 2020 · Cloud-based software solutions allow medical device manufacturers and suppliers to reduce inefficiencies, both in the warehouse and out in the field. Automating certain processes leads to full inventory visibility and greater accuracy, which helps reduce overstock and ensures all expired products are removed from hospital shelves.